InsidersTradesSigma
Jasper Therapeutics, Inc. Stock: price and directors' dealings · United States · SEC (Form 4)
Track the Jasper Therapeutics, Inc. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on US US, under the oversight of SEC (Form 4). Operating in the Health Care sector, Jasper Therapeutics, Inc. has published 32 insider filings. Market capitalisation: €22m. The latest transaction was disclosed on 12 December 2024 (Levée d'options). Among the most active insiders: Mahal Jeetinder Singh. All data is accessible without an account.
32
Insider Decl.
0
Thresholds
€14m
7 ops.
Buy Volume
€216,854
6 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Jasper Therapeutics, Inc. Buy (bullish), based on 5 analysts. Average price target: US$7.50.
45Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 12 December 2024
Declarations32 total
900 shares@ US$7.105.6% of flowVoting Common StockSEC:0001213900-24-108551:0
900 shares@ US$7.105.3% of flowVoting Common StockSEC:0001213900-24-078214:0
900 shares@ US$7.105.4% of flowVoting Common StockSEC:0001213900-24-052215:0
400 shares@ US$4.1735100.0% of flowVoting Common StockSEC:0001213900-24-051417:0
900 shares@ US$7.105.4% of flowVoting Common StockSEC:0001213900-24-021961:0
190,000 shares@ US$12.9534.6% of flowVoting Common StockSEC:0000950170-24-014017:0
Ideal exit: 4 Nov 2024 (T+270)
350,000 shares@ US$12.95100.0% of flowCommon Stock, par value $0.0001 per shareSEC:0000921895-24-000337:0
Ideal exit: 4 Nov 2024 (T+270)
10,000 shares@ US$0.648634.3% of flowVoting Common StockSEC:0001213900-23-091458:0
Ideal exit: 24 Aug 2024 (T+270)
10,000 shares@ US$0.638333.8% of flowVoting Common StockSEC:0001213900-23-089579:0
Ideal exit: 17 Aug 2024 (T+270)
10,000 shares@ US$0.596531.9% of flowVoting Common StockSEC:0001213900-23-088896:0
Ideal exit: 12 Aug 2024 (T+270)
87,531 shares@ US$0.8537.8% of flowVoting Common StockSEC:0001013762-23-003902:0
37,126 shares@ US$0.8527.5% of flowVoting Common StockSEC:0001013762-23-003903:0
7,965 shares@ US$0.85089.9% of flowVoting Common StockSEC:0001013762-23-003901:0
9,000 shares@ US$0.715.4% of flowVoting Common StockSEC:0001213900-23-048683:0
8,500 shares@ US$1.4417.0% of flowVoting Common StockSEC:0001213900-23-029888:0
7,000 shares@ US$1.48100.0% of flowVoting Common StockSEC:0001213900-23-029901:0
9,075 shares@ US$1.4903100.0% of flowVoting Common StockSEC:0001213900-23-029900:0
37,126 shares@ US$1.4645.3% of flowVoting Common StockSEC:0001213900-23-029893:0
87,531 shares@ US$1.4662.2% of flowVoting Common StockSEC:0001213900-23-029896:0
2,666,666 shares@ US$1.50100.0% of flowVoting Common StockSEC:0001209191-23-024058:0
Ideal exit: 24 Oct 2023 (T+270)
3,133,333 shares@ US$1.5065.4% of flowVoting Common StockSEC:0000899243-23-003059:0
Ideal exit: 24 Oct 2023 (T+270)
75,000 shares@ US$1.89100.0% of flowVoting Common StockSEC:0001104659-23-007094:0
29,500 shares0Voting Common StockSEC:0001213900-22-063943:0
24,500 shares0Voting Common StockSEC:0001213900-22-063947:0
506,250 shares0Voting Common StockSEC:0001213900-22-063949:0
25 of 32 declarations